Cargando…
Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing’s disease
Recurrence of Cushing’s disease after successful transsphenoidal surgery occurs in some 30% of the patients and the response to desmopressin shortly after surgery has been proposed as a marker for disease recurrence. The aim of the present study was to evaluate the response to desmopressin over time...
Autores principales: | Ambrogio, Alberto Giacinto, Andrioli, Massimiliano, De Martin, Martina, Cavagnini, Francesco, Pecori Giraldi, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682421/ https://www.ncbi.nlm.nih.gov/pubmed/29018154 http://dx.doi.org/10.1530/EC-17-0292 |
Ejemplares similares
-
Variability in laboratory parameters used for management of Cushing’s syndrome
por: Pecori Giraldi, Francesca, et al.
Publicado: (2015) -
Role of “old” pharmacological agents in the treatment of Cushing’s syndrome
por: Ambrogio, A. G., et al.
Publicado: (2016) -
Desmopressin Stimulation Test in a Pregnant Patient with Cushing's Disease
por: Parksook, Wasita Warachit, et al.
Publicado: (2021) -
Role of the ubiquitin/proteasome system on ACTH turnover in rat corticotropes
por: Sesta, Antonella, et al.
Publicado: (2018) -
Gene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles
por: Cassarino, Maria Francesca, et al.
Publicado: (2018)